Precision medicine could be the next great transformation in the evolution of healthcare delivery. Treating patients based on their individual traits and genetics could bring about great changes in patient outcomes and the quality of healthcare. It could even trim costs from the delivery of care.

The HIMSS18 “Precision Medicine Symposium: Journey to the Summit Using Clinical and Business Intelligence,” will explore clinical and business intelligence, including the current landscape, future vision, and stakeholder challenges and perspectives.

Precision medicine is a fast-evolving field of healthcare that is approaching the mainstream tipping point. Clinical and business intelligence is instrumental in transitioning precision medicine to routine care by delivering analytics, data interoperability and data sharing among the ecosystems’ stakeholders – laboratories, health systems, pharma, EHR vendors, researchers and payers – to inform decision-making in the provider workflow.

The opening keynote address at the symposium is entitled “Precision Medicine at the Inflection Point.” The speaker is Damon Hostin, CEO of the Precision Medicine Alliance. This keynote highlights the ecosystem and the drivers impacting precision medicine and the role of clinical and business intelligence.

The journey to the summit begins with a systematic understanding of foundational elements of successful precision medicine treatments. This session provides the current status of precision medicine and an overview of current regulatory, technology and market drivers impacting key healthcare systems striving to implement precision medicine.

The closing keynote address is entitled “Going from the Trail to the Summit in Precision Medicine.” The speaker is Steven Kalkanis, MD, medical director of the Henry Ford Cancer Institute and chair of the Department of Neurosurgery at Henry Ford Health System.

Precision medicine has the potential to blaze new trails delivering structural changes to the healthcare industry by improving diagnosis, treatment and patient prognosis. The arrival of precision medicine to routine care is imminent but how do healthcare organizations get there? Successful and appropriate adoption across the healthcare ecosystem will be vital, Kalkanis said. .

The HIMSS18 “Precision Medicine Symposium: Journey to the Summit Using Clinical and Business Intelligence,” is scheduled 8 a.m. to 4:30 p.m. March 5 at the Venetian-Palazzo-Sands Expo Center. The symposium costs $350.

Twitter: @SiwickiHealthIT
Email the writer: bill.siwicki@himssmedia.com